SIRT1 and amyotrophic lateral sclerosis: These results suggested that A‐1 treatment improved mitochondrial function by activating AMPK/SIRT1/PGC‐1α, which in turn increased mitochondrial biogenesis and further delayed the progression of ALS disease.